NICE Gives Nucala Initial OK In Severe Asthma After GSK Offers Price Cut

Adult patients with severe eosinophilic asthma in England and Wales look set to get a much needed treatment option following NICE's provisional backing of GlaxoSmithKline's new MAb therapy.